Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Gastroenterology|February 1, 1993
Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)J P Gendre, J Y Mary, C Florent, et al.
Annales De Gastroenterologie Et D'Hepatologie|October 1, 1993
[Maintenance treatment of Crohn's disease using orally administered mesalazine (Pentasa). A controlled multicenter study. The Study Groups on the Treatment of Inflammatory Digestive Disorders]J P Gendre, J Y Mary, C Florent, et al.
Gastroenterology|June 2, 2000
Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapyJ F Colombel, N Ferrari, H Debuysere, et al.
Alimentary Pharmacology & Therapeutics|May 15, 2009
Association between entero-hepatic Helicobacter species and Crohn's disease: a prospective cross-sectional studyD Laharie, C Asencio, J Asselineau, et al.
Alimentary Pharmacology & Therapeutics|May 28, 2011
Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohortA Vienne, T Simon, J Cosnes, et al.
Gastroenterology|March 1, 1996
Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires DigestivesR Modigliani, J F Colombel, J L Dupas, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1996
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)C Florent, A Cortot, P Quandale, et al.
Gut|December 27, 2005
Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trialP Marteau, M Lémann, P Seksik, et al.
Pageof 4